Tisotumab vedotin Completed Phase 2 Trials for Cervical Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03438396
A Trial of Tisotumab Vedotin in Cervical Cancer